Correspondence 0001104659-24-091986 from Sagimet Biosciences Inc. (SGMT)
Sagimet Biosciences Inc.
Date: Aug. 22, 2024 · CIK: 0001400118 · Accession: 0001104659-24-091986
AI Filing Summary & Sentiment
File numbers found in text: 333-281582
Letter
Sagimet Biosciences Inc.
155 Bovet Road, Suite 303
San Mateo, California 94402
August 22, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-7553
Re: Sagimet Biosciences Inc.
Registration Statement on Form S-3
Filed August 15, 2024 (File No. 333-281582)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Sagimet Biosciences Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-281582) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:01 P.M., Eastern Time, on August 26, 2024, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time.
Please contact Jennifer L. Porter, Esq. of Goodwin Procter LLP, at (445) 207-7806 to provide notice of effectiveness, or if you have any questions or comments concerning this request.
[Remainder of the page intentionally left blank]
Very truly yours,
SAGIMET BIOSCIENCES INC.
Show Raw Text
CORRESP
1
filename1.htm
Sagimet Biosciences Inc.
155 Bovet Road, Suite 303
San Mateo, California 94402
August 22, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-7553
Re: Sagimet Biosciences Inc.
Registration Statement on Form S-3
Filed August 15, 2024 (File No. 333-281582)
Ladies and Gentlemen:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, Sagimet Biosciences Inc. (the “Company”) hereby requests
that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-281582) (the “Registration
Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:01 P.M., Eastern
Time, on August 26, 2024, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration
Statement be declared effective at some other time.
Please contact Jennifer L.
Porter, Esq. of Goodwin Procter LLP, at (445) 207-7806 to provide notice of effectiveness, or if you have
any questions or comments concerning this request.
[Remainder of the page intentionally left
blank]
Very truly yours,
SAGIMET BIOSCIENCES INC.
By:
/s/ David Happel
Name:
David Happel
Title:
President and Chief Executive Officer